An integrated view of cisplatin-induced nephrotoxicity and ototoxicity

Takatoshi Karasawa, Peter Steyger

Research output: Contribution to journalArticle

137 Citations (Scopus)

Abstract

Cisplatin is one of the most widely-used drugs to treat cancers. However, its nephrotoxic and ototoxic side-effects remain major clinical limitations. Recent studies have improved our understanding of the molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. While cisplatin binding to DNA is the major cytotoxic mechanism in proliferating (cancer) cells, nephrotoxicity and ototoxicity appear to result from toxic levels of reactive oxygen species and protein dysregulation within various cellular compartments. In this review, we discuss molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. We also discuss potential clinical strategies to prevent nephrotoxicity and ototoxicity and their current limitations.

Original languageEnglish (US)
Pages (from-to)219-227
Number of pages9
JournalToxicology Letters
Volume237
Issue number3
DOIs
StatePublished - Sep 7 2015

Fingerprint

Cisplatin
Poisons
Reactive Oxygen Species
Neoplasms
DNA
Pharmaceutical Preparations
Proteins

Keywords

  • Cisplatin
  • Intracellular mechanisms
  • Nephrotoxicity
  • Ototoxicity

ASJC Scopus subject areas

  • Toxicology

Cite this

An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. / Karasawa, Takatoshi; Steyger, Peter.

In: Toxicology Letters, Vol. 237, No. 3, 07.09.2015, p. 219-227.

Research output: Contribution to journalArticle

@article{8e1c4862280d4e1d8d82f4acf3789907,
title = "An integrated view of cisplatin-induced nephrotoxicity and ototoxicity",
abstract = "Cisplatin is one of the most widely-used drugs to treat cancers. However, its nephrotoxic and ototoxic side-effects remain major clinical limitations. Recent studies have improved our understanding of the molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. While cisplatin binding to DNA is the major cytotoxic mechanism in proliferating (cancer) cells, nephrotoxicity and ototoxicity appear to result from toxic levels of reactive oxygen species and protein dysregulation within various cellular compartments. In this review, we discuss molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. We also discuss potential clinical strategies to prevent nephrotoxicity and ototoxicity and their current limitations.",
keywords = "Cisplatin, Intracellular mechanisms, Nephrotoxicity, Ototoxicity",
author = "Takatoshi Karasawa and Peter Steyger",
year = "2015",
month = "9",
day = "7",
doi = "10.1016/j.toxlet.2015.06.012",
language = "English (US)",
volume = "237",
pages = "219--227",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - An integrated view of cisplatin-induced nephrotoxicity and ototoxicity

AU - Karasawa, Takatoshi

AU - Steyger, Peter

PY - 2015/9/7

Y1 - 2015/9/7

N2 - Cisplatin is one of the most widely-used drugs to treat cancers. However, its nephrotoxic and ototoxic side-effects remain major clinical limitations. Recent studies have improved our understanding of the molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. While cisplatin binding to DNA is the major cytotoxic mechanism in proliferating (cancer) cells, nephrotoxicity and ototoxicity appear to result from toxic levels of reactive oxygen species and protein dysregulation within various cellular compartments. In this review, we discuss molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. We also discuss potential clinical strategies to prevent nephrotoxicity and ototoxicity and their current limitations.

AB - Cisplatin is one of the most widely-used drugs to treat cancers. However, its nephrotoxic and ototoxic side-effects remain major clinical limitations. Recent studies have improved our understanding of the molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. While cisplatin binding to DNA is the major cytotoxic mechanism in proliferating (cancer) cells, nephrotoxicity and ototoxicity appear to result from toxic levels of reactive oxygen species and protein dysregulation within various cellular compartments. In this review, we discuss molecular mechanisms of cisplatin-induced nephrotoxicity and ototoxicity. We also discuss potential clinical strategies to prevent nephrotoxicity and ototoxicity and their current limitations.

KW - Cisplatin

KW - Intracellular mechanisms

KW - Nephrotoxicity

KW - Ototoxicity

UR - http://www.scopus.com/inward/record.url?scp=84934764055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934764055&partnerID=8YFLogxK

U2 - 10.1016/j.toxlet.2015.06.012

DO - 10.1016/j.toxlet.2015.06.012

M3 - Article

C2 - 26101797

AN - SCOPUS:84934764055

VL - 237

SP - 219

EP - 227

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

IS - 3

ER -